APA (7th ed.) Citation

Saleh, D. O., Abo El Nasr, N. M., Elbaset, M. A., Shabana, M. E., Esatbeyoglu, T., Afifi, S. M., & Hashad, I. M. (2025). Role of rosuvastatin and pitavastatin in alleviating diabetic cardiomyopathy in rats: Targeting of RISK, NF-κB/ NLRP3 inflammasome and TLR4/ NF-κB signaling cascades. PLoS ONE, 20(7), 1. https://doi.org/10.1371/journal.pone.0325767

Chicago Style (17th ed.) Citation

Saleh, Dalia O., Nesma M.E Abo El Nasr, Marawan A. Elbaset, Marwa E. Shabana, Tuba Esatbeyoglu, Sherif M. Afifi, and Ingy M. Hashad. "Role of Rosuvastatin and Pitavastatin in Alleviating Diabetic Cardiomyopathy in Rats: Targeting of RISK, NF-κB/ NLRP3 Inflammasome and TLR4/ NF-κB Signaling Cascades." PLoS ONE 20, no. 7 (2025): 1. https://doi.org/10.1371/journal.pone.0325767.

MLA (9th ed.) Citation

Saleh, Dalia O., et al. "Role of Rosuvastatin and Pitavastatin in Alleviating Diabetic Cardiomyopathy in Rats: Targeting of RISK, NF-κB/ NLRP3 Inflammasome and TLR4/ NF-κB Signaling Cascades." PLoS ONE, vol. 20, no. 7, 2025, p. 1, https://doi.org/10.1371/journal.pone.0325767.